Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39.01 USD | +2.60% | -0.15% | -18.47% |
14/06 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating | MT |
14/06 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- MarketScreener Strategies